The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins
We cant change the structure of things like how a state runs its health insurance, but we can build parallel systems and operationalize the actions we can take as physicians, caregivers, and people living with type 1 diabetes to make sure some of those gaps can be bridged. Addalas team will also be assessing these intervention strategies in a trial for youth with type 1 diabetes under the age of 12
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide (October 17, 2024) Tirzepatide And Muscle Composition Changes In People With Type 2 Diabetes (SURPASS-3 MRI): A Post-Hoc Analysis Of A Randomised, Open-Label, Parallel-Group, Phase 3 Trial (April 30, 2025) Changes In Lean Body Mass With Glucagon-Like Peptide-1-Based Therapies And Mitigation Strategies (June 27, 2024) Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (July 8, 2025) WEGOVY (semaglutide) Prescribing Information (November 2024)
Its different
While you sleep, your brain does much more than rest
